The premier event in classical and malignant hematology is headed to San Diego!

The 65th ASH Annual Meeting and Exposition will take place December 9-12, 2023, in San Diego, California, and online. Mark your calendars now to attend the world’s most comprehensive hematology event of the year.

2023 ASH Annual Meeting

65TH ASH ANNUAL MEETING AND EXPOSITION

December 9-12, 2023 | View Key Dates
San Diego, California, and online

Registration is now open for members, non-members, groups, exhibitors, and media!

View Registration Information

An speaker presents her abstract poster to an attendee

2023 ASH Annual Meeting Abstracts

Abstracts for the 2023 ASH Annual Meeting and Exposition are now available. View more than 7,000 accepted abstracts representing the most cutting-edge science in hematology.

Late-Breaking Abstracts are now available!

Access the 2023 Abstracts

2023 ASH Annual Meeting App

Elevate your ASH annual meeting experience with the ASH Annual Meeting app, providing access to the full annual meeting program, abstracts, and a host of features for seamless navigation and engagement.

Download the App

Health and Safety

COVID-19 vaccination is not required, but is encouraged, for in-person meeting attendees travelling to San Diego for the 65th ASH Annual Meeting and Exposition. The wearing of protective masks is encouraged, but optional. We encourage you to monitor the Health and Safety Information webpage to stay abreast of any updates.

View Health and Safety Information

Government Concierge

ASH understands that federal agencies within the U.S. government are adjusting and developing new guidelines for conference attendance for their employees and that each agency will have its own policy. To assist federal employees by providing information that will help with their attendance requests, applications for funding approval, and housing needs, ASH has established a Government Concierge.

Visit the Government Concierge Page

Key Dates for the 65th ASH Annual Meeting and Exposition

June 1, 2023	Abstract Submission Site Opens
July 19, 2023	Registration and Housing Open for ASH Members
July 26, 2023	Ancillary Meeting Room Request Form Available
August 1, 2023	Abstract Submission Deadline
August 9, 2023	Advance Registration and Housing Opens for Non-Members, Groups, Exhibitors, and Media
October 17-26, 2023	Call for Late Breaking Abstract Submissions
October 25, 2023 at 11:59 p.m. Pacific time	Advance Registration Period and Discount Ends
October 26, 2023 at 12:00 a.m. Pacific time	Late/On-Site Registration Begins
November 2, 2023 at 9:00 a.m. Eastern time	Abstracts Available Online
November 8, 2023 at 5:00 p.m. Eastern time	Hotel Reservation Deadline Registration Cancellation Deadline
November 17, 2023 at 11:59 p.m. Pacific time	Ancillary Meeting Room Request Deadline
November 21, 2023	Late Breaking Abstracts Available Online
December 6-8, 2023	Virtual Platform Opens (meeting preview days)
December 8, 2023	ASH-a-Palooza Scientific Workshops Friday Satellite Symposia
December 9-12, 2023	65th ASH Annual Meeting and Exposition \| View the Schedule-at-a-Glance
January 1, 2024 at 11:59 p.m. Pacific time	Real-Time Experience Virtual Access Ends
February 1, 2024 at 11:59 p.m. Pacific time	Extended Flexibility Virtual Access Ends
March 1, 2024 at 11:59 p.m. Pacific time	Best Value Virtual Access Ends (and virtual platform closes)

Add Meeting to Calendar

Past Annual Meetings

64th ASH Annual Meeting and Exposition
December 10-13, 2022
New Orleans, LA

63rd ASH Annual Meeting and Exposition
December 11-14, 2021
Atlanta, GA

Access Annual Meetings since 2014

Acknowledgements

ASH would like to acknowledge the following companies for the education grants provided in support of the 2023 ASH Annual Meeting:

Hematology 2023: The ASH Education Program

AstraZeneca
Incyte Corportation
Jazz Pharmaceuticals
Merck Sharp & Dohme LLC
Novartis Pharmaceuticals Corporation

General Education Grants

AbbVie
AstraZeneca
Incyte Corportation
Lilly USA, LLC
Merck Sharp & Dohme LLC
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Seagen
Syndax Pharmaceuticals, Inc.